<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font5" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font6" size="10" family="Symbol" color="#000000"/>
	<fontspec id="font7" size="8" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font8" size="8" family="GillSans" color="#000000"/>
<text top="41" left="55" width="132" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title"><i>Journal of Autoimmune Diseases</i></text>
<text top="41" left="187" width="27" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="0" tag_type="title"> 2005, </text>
<text top="41" left="214" width="5" height="10" font="font2" id="p1_t3" reading_order_no="2" segment_no="0" tag_type="title"><b>2</b></text>
<text top="41" left="219" width="7" height="10" font="font1" id="p1_t4" reading_order_no="3" segment_no="0" tag_type="title">:5</text>
<text top="41" left="395" width="159" height="10" font="font1" id="p1_t5" reading_order_no="4" segment_no="1" tag_type="text">http://www.jautoimdis.com/content/2/1/5</text>
<text top="756" left="508" width="46" height="10" font="font1" id="p1_t6" reading_order_no="159" segment_no="13" tag_type="text">Page 3 of 5</text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t7" reading_order_no="160" segment_no="14" tag_type="text"><i>(page number not for citation purposes)</i></text>
<text top="566" left="55" width="241" height="9" font="font4" id="p1_t8" reading_order_no="89" segment_no="9" tag_type="text">subjects were stratified by sex, age, and CFS for all MAP2,</text>
<text top="578" left="55" width="241" height="9" font="font4" id="p1_t9" reading_order_no="90" segment_no="9" tag_type="text">NFT and ssDNA. The association of autoantibodes in CFS</text>
<text top="590" left="55" width="241" height="9" font="font4" id="p1_t10" reading_order_no="91" segment_no="9" tag_type="text">subjects was compared by grouping by sex, age, age at ill-</text>
<text top="601" left="55" width="241" height="9" font="font4" id="p1_t11" reading_order_no="92" segment_no="9" tag_type="text">ness onset, and duration of illness. CFS subjects were strat-</text>
<text top="613" left="55" width="241" height="9" font="font4" id="p1_t12" reading_order_no="93" segment_no="9" tag_type="text">ified by sex, age (&lt;40 years, 40–40 years, &gt;50 years), onset</text>
<text top="625" left="55" width="241" height="9" font="font4" id="p1_t13" reading_order_no="94" segment_no="9" tag_type="text">type (gradual versus sudden) and duration of illness (&lt;5</text>
<text top="637" left="55" width="241" height="9" font="font4" id="p1_t14" reading_order_no="95" segment_no="9" tag_type="text">years, &gt;5 years) to determine whether an association with</text>
<text top="648" left="55" width="97" height="9" font="font4" id="p1_t15" reading_order_no="96" segment_no="9" tag_type="text">autoantibodies existed.</text>
<text top="672" left="55" width="36" height="10" font="font5" id="p1_t16" reading_order_no="97" segment_no="10" tag_type="title"><b>Results</b></text>
<text top="684" left="55" width="241" height="9" font="font4" id="p1_t17" reading_order_no="98" segment_no="11" tag_type="text">Although women predominated in both study groups</text>
<text top="695" left="55" width="241" height="9" font="font4" id="p1_t18" reading_order_no="99" segment_no="11" tag_type="text">other demographic and clinical characteristics differed</text>
<text top="707" left="55" width="241" height="9" font="font4" id="p1_t19" reading_order_no="100" segment_no="11" tag_type="text">and reflected basic differences between patients with CFS</text>
<text top="719" left="55" width="241" height="9" font="font4" id="p1_t20" reading_order_no="101" segment_no="11" tag_type="text">who obtain medical care and those in the general popula-</text>
<text top="87" left="313" width="241" height="9" font="font4" id="p1_t21" reading_order_no="102" segment_no="2" tag_type="text">tion (most of whom have not seen a physician) (T<a href="">able 1)</a>.</text>
<text top="98" left="313" width="241" height="9" font="font4" id="p1_t22" reading_order_no="103" segment_no="2" tag_type="text">Of note, CFS cases from physician surveillance were some-</text>
<text top="110" left="313" width="241" height="9" font="font4" id="p1_t23" reading_order_no="104" segment_no="2" tag_type="text">what younger than those identified in the population</text>
<text top="122" left="313" width="241" height="9" font="font4" id="p1_t24" reading_order_no="105" segment_no="2" tag_type="text">(mean 39 and 46 years, respectively) and controls were</text>
<text top="134" left="313" width="241" height="9" font="font4" id="p1_t25" reading_order_no="106" segment_no="2" tag_type="text">similarly different: those recruited in the physician study</text>
<text top="145" left="313" width="241" height="9" font="font4" id="p1_t26" reading_order_no="107" segment_no="2" tag_type="text">had been ill about half as long as those in the community</text>
<text top="157" left="313" width="241" height="9" font="font4" id="p1_t27" reading_order_no="108" segment_no="2" tag_type="text">(69 and 128 months, respectively) and were more likely</text>
<text top="169" left="313" width="241" height="9" font="font4" id="p1_t28" reading_order_no="109" segment_no="2" tag_type="text">to report sudden onset CFS (36.4%) than those in the gen-</text>
<text top="181" left="313" width="146" height="9" font="font4" id="p1_t29" reading_order_no="110" segment_no="2" tag_type="text">eral population with CFS (13.5%).</text>
<text top="204" left="313" width="241" height="9" font="font4" id="p1_t30" reading_order_no="111" segment_no="5" tag_type="text">A few CFS subjects in the physician surveillance study</text>
<text top="216" left="313" width="241" height="9" font="font4" id="p1_t31" reading_order_no="112" segment_no="5" tag_type="text">aged 18–29 years had antibodies to ssDNA when com-</text>
<text top="228" left="313" width="241" height="9" font="font4" id="p1_t32" reading_order_no="113" segment_no="5" tag_type="text">pared to the same age non-fatigued control group. The</text>
<text top="239" left="313" width="241" height="9" font="font4" id="p1_t33" reading_order_no="114" segment_no="5" tag_type="text">mean value for the 3 CFS subjects was 2-fold greater then</text>
<text top="251" left="313" width="241" height="9" font="font4" id="p1_t34" reading_order_no="115" segment_no="5" tag_type="text">in the 6 non-fatigued controls (p = 0.038). Among CFS</text>
<text top="263" left="313" width="184" height="9" font="font4" id="p1_t35" reading_order_no="116" segment_no="5" tag_type="text">subjects, the 10 who reported being ill for </text>
<text top="260" left="497" width="5" height="13" font="font6" id="p1_t36" reading_order_no="117" segment_no="5" tag_type="text">≤</text>
<text top="263" left="502" width="52" height="9" font="font4" id="p1_t37" reading_order_no="118" segment_no="5" tag_type="text"> 5 years had</text>
<text top="275" left="313" width="241" height="9" font="font4" id="p1_t38" reading_order_no="119" segment_no="5" tag_type="text">lower levels of autoantibodies to MAP2 (median value of</text>
<text top="286" left="313" width="241" height="9" font="font4" id="p1_t39" reading_order_no="120" segment_no="5" tag_type="text">18, range 12 – 20) compared to the 12 CFS subjects who</text>
<text top="298" left="313" width="241" height="9" font="font4" id="p1_t40" reading_order_no="121" segment_no="5" tag_type="text">have been ill for &gt;5 years (median value of 8, range 6 to</text>
<text top="310" left="313" width="241" height="9" font="font4" id="p1_t41" reading_order_no="122" segment_no="5" tag_type="text">10) (p = 0.025). There were no other significant findings</text>
<text top="322" left="313" width="241" height="9" font="font4" id="p1_t42" reading_order_no="123" segment_no="5" tag_type="text">in the physician surveillance CFS subjects when stratified</text>
<text top="333" left="313" width="125" height="9" font="font4" id="p1_t43" reading_order_no="124" segment_no="5" tag_type="text">by sex or type of illness onset.</text>
<text top="357" left="313" width="241" height="9" font="font4" id="p1_t44" reading_order_no="125" segment_no="6" tag_type="text">In the population-based study, there was a significant dif-</text>
<text top="369" left="313" width="241" height="9" font="font4" id="p1_t45" reading_order_no="126" segment_no="6" tag_type="text">ference in the prevalence of autoantibodies to MAP2</text>
<text top="380" left="313" width="241" height="9" font="font4" id="p1_t46" reading_order_no="127" segment_no="6" tag_type="text">between the 30 male subjects (20/30, 67% positive) and</text>
<text top="392" left="313" width="241" height="9" font="font4" id="p1_t47" reading_order_no="128" segment_no="6" tag_type="text">the 64 female subjects (19/64, 30% positive) (p =</text>
<text top="404" left="313" width="241" height="9" font="font4" id="p1_t48" reading_order_no="129" segment_no="6" tag_type="text">0.0006). Among the non-fatigued control group, 9 of 33</text>
<text top="416" left="313" width="241" height="9" font="font4" id="p1_t49" reading_order_no="130" segment_no="6" tag_type="text">women (27%) and 19 of 24 (79%) men were positive for</text>
<text top="427" left="313" width="241" height="9" font="font4" id="p1_t50" reading_order_no="131" segment_no="6" tag_type="text">antibodies to MAP2 (p = 0.0004). One male CFS subject</text>
<text top="439" left="313" width="241" height="9" font="font4" id="p1_t51" reading_order_no="132" segment_no="6" tag_type="text">(16%) was positive for MAP2 antibodies compared to</text>
<text top="451" left="313" width="241" height="9" font="font4" id="p1_t52" reading_order_no="133" segment_no="6" tag_type="text">79% (19/24) male non-fatigued controls (p = 0.04).</text>
<text top="463" left="313" width="128" height="9" font="font4" id="p1_t53" reading_order_no="134" segment_no="6" tag_type="text">Among CFS subjects that were </text>
<text top="460" left="441" width="5" height="13" font="font6" id="p1_t54" reading_order_no="135" segment_no="6" tag_type="text">≤</text>
<text top="463" left="446" width="108" height="9" font="font4" id="p1_t55" reading_order_no="136" segment_no="6" tag_type="text"> 40 years of age, there was</text>
<text top="474" left="313" width="241" height="9" font="font4" id="p1_t56" reading_order_no="137" segment_no="6" tag_type="text">a trend for lower MAP2 antibody levels for those that were</text>
<text top="486" left="313" width="28" height="9" font="font4" id="p1_t57" reading_order_no="138" segment_no="6" tag_type="text">ill for </text>
<text top="483" left="341" width="5" height="13" font="font6" id="p1_t58" reading_order_no="139" segment_no="6" tag_type="text">≤</text>
<text top="486" left="346" width="208" height="9" font="font4" id="p1_t59" reading_order_no="140" segment_no="6" tag_type="text"> 5 years compared to those ill for &gt;5 years (p =</text>
<text top="498" left="313" width="31" height="9" font="font4" id="p1_t60" reading_order_no="141" segment_no="6" tag_type="text">0.056).</text>
<text top="522" left="313" width="52" height="10" font="font5" id="p1_t61" reading_order_no="142" segment_no="7" tag_type="title"><b>Discussion</b></text>
<text top="533" left="313" width="241" height="9" font="font4" id="p1_t62" reading_order_no="143" segment_no="8" tag_type="text">CFS is a complex, debilitating illness, which is character-</text>
<text top="545" left="313" width="241" height="9" font="font4" id="p1_t63" reading_order_no="144" segment_no="8" tag_type="text">ized by at least 6 months of severe persistent or relapsing</text>
<text top="557" left="313" width="241" height="9" font="font4" id="p1_t64" reading_order_no="145" segment_no="8" tag_type="text">fatigue and a group of characteristic but nonspecific symp-</text>
<text top="568" left="313" width="241" height="9" font="font4" id="p1_t65" reading_order_no="146" segment_no="8" tag_type="text">toms. Despite more than a two decades of extensive</text>
<text top="580" left="313" width="241" height="9" font="font4" id="p1_t66" reading_order_no="147" segment_no="8" tag_type="text">research, no diagnostic tests exist, and effective control</text>
<text top="592" left="313" width="241" height="9" font="font4" id="p1_t67" reading_order_no="148" segment_no="8" tag_type="text">and prevention remain elusive because the cause and</text>
<text top="604" left="313" width="241" height="9" font="font4" id="p1_t68" reading_order_no="149" segment_no="8" tag_type="text">pathophysiology of CFS remain unknown. CFS is clini-</text>
<text top="615" left="313" width="241" height="9" font="font4" id="p1_t69" reading_order_no="150" segment_no="8" tag_type="text">cally similar to several rheumatic autoimmune disorders</text>
<text top="627" left="313" width="241" height="9" font="font4" id="p1_t70" reading_order_no="151" segment_no="8" tag_type="text">that can be diagnosed and characterized by autoantibody</text>
<text top="639" left="313" width="241" height="9" font="font4" id="p1_t71" reading_order_no="152" segment_no="8" tag_type="text">profiles. For this reason, we conducted an exhaustive eval-</text>
<text top="651" left="313" width="241" height="9" font="font4" id="p1_t72" reading_order_no="153" segment_no="8" tag_type="text">uation of 11 ubiquitous nuclear and cellular autoantigens</text>
<text top="662" left="313" width="191" height="9" font="font4" id="p1_t73" reading_order_no="154" segment_no="8" tag_type="text">in addition to two neuronal specific antigens.</text>
<text top="686" left="313" width="241" height="9" font="font4" id="p1_t74" reading_order_no="155" segment_no="12" tag_type="text">The serum samples tested in this study were collected</text>
<text top="698" left="313" width="241" height="9" font="font4" id="p1_t75" reading_order_no="156" segment_no="12" tag_type="text">from a physician surveillance study conducted in Atlanta</text>
<text top="709" left="313" width="241" height="9" font="font4" id="p1_t76" reading_order_no="157" segment_no="12" tag_type="text"><a href="">[15] </a>and a population-based community study in Wichita</text>
<text top="721" left="313" width="241" height="9" font="font4" id="p1_t77" reading_order_no="158" segment_no="12" tag_type="text"><a href="">[8]. Th</a>e physician surveillance study was conducted over</text>
<text top="87" left="55" width="184" height="7" font="font7" id="p1_t78" reading_order_no="5" segment_no="3" tag_type="title"><b>Table 1: Characteristics of subjects evaluated for </b></text>
<text top="96" left="55" width="57" height="7" font="font7" id="p1_t79" reading_order_no="6" segment_no="3" tag_type="title"><b>autoantibodies.</b></text>
<text top="114" left="188" width="13" height="7" font="font8" id="p1_t80" reading_order_no="7" segment_no="4" tag_type="table">CFS</text>
<text top="114" left="239" width="45" height="7" font="font8" id="p1_t81" reading_order_no="8" segment_no="4" tag_type="table">Non-Fatigued</text>
<text top="137" left="59" width="72" height="7" font="font8" id="p1_t82" reading_order_no="9" segment_no="4" tag_type="table">Atlanta Case Control</text>
<text top="147" left="59" width="57" height="7" font="font8" id="p1_t83" reading_order_no="10" segment_no="4" tag_type="table">Subjects (n = 56)</text>
<text top="147" left="191" width="8" height="7" font="font8" id="p1_t84" reading_order_no="11" segment_no="4" tag_type="table">22</text>
<text top="147" left="258" width="8" height="7" font="font8" id="p1_t85" reading_order_no="12" segment_no="4" tag_type="table">34</text>
<text top="157" left="59" width="53" height="7" font="font8" id="p1_t86" reading_order_no="13" segment_no="4" tag_type="table">Female (n = 52)</text>
<text top="157" left="191" width="8" height="7" font="font8" id="p1_t87" reading_order_no="14" segment_no="4" tag_type="table">19</text>
<text top="157" left="258" width="8" height="7" font="font8" id="p1_t88" reading_order_no="15" segment_no="4" tag_type="table">33</text>
<text top="167" left="59" width="41" height="7" font="font8" id="p1_t89" reading_order_no="16" segment_no="4" tag_type="table">Male (n = 4)</text>
<text top="167" left="193" width="4" height="7" font="font8" id="p1_t90" reading_order_no="17" segment_no="4" tag_type="table">3</text>
<text top="167" left="260" width="4" height="7" font="font8" id="p1_t91" reading_order_no="18" segment_no="4" tag_type="table">1</text>
<text top="178" left="59" width="55" height="7" font="font8" id="p1_t92" reading_order_no="19" segment_no="4" tag_type="table">Age Group (yrs)</text>
<text top="188" left="59" width="46" height="7" font="font8" id="p1_t93" reading_order_no="20" segment_no="4" tag_type="table">18–29 (n = 9)</text>
<text top="188" left="193" width="4" height="7" font="font8" id="p1_t94" reading_order_no="21" segment_no="4" tag_type="table">3</text>
<text top="188" left="260" width="4" height="7" font="font8" id="p1_t95" reading_order_no="22" segment_no="4" tag_type="table">6</text>
<text top="198" left="59" width="50" height="7" font="font8" id="p1_t96" reading_order_no="23" segment_no="4" tag_type="table">30–39 (n = 18)</text>
<text top="198" left="193" width="4" height="7" font="font8" id="p1_t97" reading_order_no="24" segment_no="4" tag_type="table">7</text>
<text top="198" left="258" width="8" height="7" font="font8" id="p1_t98" reading_order_no="25" segment_no="4" tag_type="table">11</text>
<text top="208" left="59" width="50" height="7" font="font8" id="p1_t99" reading_order_no="26" segment_no="4" tag_type="table">40–49 (n = 23)</text>
<text top="208" left="191" width="8" height="7" font="font8" id="p1_t100" reading_order_no="27" segment_no="4" tag_type="table">12</text>
<text top="208" left="258" width="8" height="7" font="font8" id="p1_t101" reading_order_no="28" segment_no="4" tag_type="table">11</text>
<text top="219" left="59" width="46" height="7" font="font8" id="p1_t102" reading_order_no="29" segment_no="4" tag_type="table">50–59 (n = 6)</text>
<text top="219" left="193" width="4" height="7" font="font8" id="p1_t103" reading_order_no="30" segment_no="4" tag_type="table">0</text>
<text top="219" left="260" width="4" height="7" font="font8" id="p1_t104" reading_order_no="31" segment_no="4" tag_type="table">6</text>
<text top="229" left="59" width="33" height="7" font="font8" id="p1_t105" reading_order_no="32" segment_no="4" tag_type="table">Mean Age</text>
<text top="229" left="181" width="28" height="7" font="font8" id="p1_t106" reading_order_no="33" segment_no="4" tag_type="table">39 years</text>
<text top="229" left="248" width="28" height="7" font="font8" id="p1_t107" reading_order_no="34" segment_no="4" tag_type="table">38 years</text>
<text top="239" left="59" width="56" height="7" font="font8" id="p1_t108" reading_order_no="35" segment_no="4" tag_type="table">Mean Age Onset</text>
<text top="239" left="181" width="28" height="7" font="font8" id="p1_t109" reading_order_no="36" segment_no="4" tag_type="table">35 years</text>
<text top="249" left="59" width="37" height="7" font="font8" id="p1_t110" reading_order_no="37" segment_no="4" tag_type="table">Onset type</text>
<text top="260" left="69" width="24" height="7" font="font8" id="p1_t111" reading_order_no="38" segment_no="4" tag_type="table">Sudden</text>
<text top="260" left="193" width="4" height="7" font="font8" id="p1_t112" reading_order_no="39" segment_no="4" tag_type="table">8</text>
<text top="270" left="69" width="27" height="7" font="font8" id="p1_t113" reading_order_no="40" segment_no="4" tag_type="table">Gradual</text>
<text top="270" left="191" width="8" height="7" font="font8" id="p1_t114" reading_order_no="41" segment_no="4" tag_type="table">14</text>
<text top="280" left="59" width="73" height="7" font="font8" id="p1_t115" reading_order_no="42" segment_no="4" tag_type="table">Mean Illness Duration</text>
<text top="280" left="177" width="36" height="7" font="font8" id="p1_t116" reading_order_no="43" segment_no="4" tag_type="table">69 months</text>
<text top="290" left="59" width="75" height="7" font="font8" id="p1_t117" reading_order_no="44" segment_no="4" tag_type="table">Number of Subjects Ill</text>
<text top="301" left="69" width="31" height="7" font="font8" id="p1_t118" reading_order_no="45" segment_no="4" tag_type="table">&lt; 5 years</text>
<text top="301" left="191" width="8" height="7" font="font8" id="p1_t119" reading_order_no="46" segment_no="4" tag_type="table">10</text>
<text top="311" left="69" width="29" height="7" font="font8" id="p1_t120" reading_order_no="47" segment_no="4" tag_type="table">&gt;5 years</text>
<text top="311" left="191" width="8" height="7" font="font8" id="p1_t121" reading_order_no="48" segment_no="4" tag_type="table">12</text>
<text top="331" left="59" width="64" height="7" font="font8" id="p1_t122" reading_order_no="49" segment_no="4" tag_type="table">Wichita Population</text>
<text top="342" left="59" width="57" height="7" font="font8" id="p1_t123" reading_order_no="50" segment_no="4" tag_type="table">Subjects (n = 94)</text>
<text top="342" left="191" width="8" height="7" font="font8" id="p1_t124" reading_order_no="51" segment_no="4" tag_type="table">37</text>
<text top="342" left="258" width="8" height="7" font="font8" id="p1_t125" reading_order_no="52" segment_no="4" tag_type="table">57</text>
<text top="352" left="59" width="53" height="7" font="font8" id="p1_t126" reading_order_no="53" segment_no="4" tag_type="table">Female (n = 64)</text>
<text top="352" left="191" width="8" height="7" font="font8" id="p1_t127" reading_order_no="54" segment_no="4" tag_type="table">31</text>
<text top="352" left="258" width="8" height="7" font="font8" id="p1_t128" reading_order_no="55" segment_no="4" tag_type="table">33</text>
<text top="362" left="59" width="45" height="7" font="font8" id="p1_t129" reading_order_no="56" segment_no="4" tag_type="table">Male (n = 30)</text>
<text top="362" left="193" width="4" height="7" font="font8" id="p1_t130" reading_order_no="57" segment_no="4" tag_type="table">6</text>
<text top="362" left="258" width="8" height="7" font="font8" id="p1_t131" reading_order_no="58" segment_no="4" tag_type="table">24</text>
<text top="372" left="59" width="55" height="7" font="font8" id="p1_t132" reading_order_no="59" segment_no="4" tag_type="table">Age Group (yrs)</text>
<text top="383" left="59" width="50" height="7" font="font8" id="p1_t133" reading_order_no="60" segment_no="4" tag_type="table">18–29 (n = 14)</text>
<text top="383" left="193" width="4" height="7" font="font8" id="p1_t134" reading_order_no="61" segment_no="4" tag_type="table">1</text>
<text top="383" left="258" width="8" height="7" font="font8" id="p1_t135" reading_order_no="62" segment_no="4" tag_type="table">13</text>
<text top="393" left="59" width="50" height="7" font="font8" id="p1_t136" reading_order_no="63" segment_no="4" tag_type="table">30–39 (n = 18)</text>
<text top="393" left="193" width="4" height="7" font="font8" id="p1_t137" reading_order_no="64" segment_no="4" tag_type="table">8</text>
<text top="393" left="258" width="8" height="7" font="font8" id="p1_t138" reading_order_no="65" segment_no="4" tag_type="table">10</text>
<text top="403" left="59" width="50" height="7" font="font8" id="p1_t139" reading_order_no="66" segment_no="4" tag_type="table">40–49 (n = 26)</text>
<text top="403" left="191" width="8" height="7" font="font8" id="p1_t140" reading_order_no="67" segment_no="4" tag_type="table">13</text>
<text top="403" left="258" width="8" height="7" font="font8" id="p1_t141" reading_order_no="68" segment_no="4" tag_type="table">13</text>
<text top="413" left="59" width="50" height="7" font="font8" id="p1_t142" reading_order_no="69" segment_no="4" tag_type="table">50–69 (n = 36)</text>
<text top="413" left="191" width="8" height="7" font="font8" id="p1_t143" reading_order_no="70" segment_no="4" tag_type="table">15</text>
<text top="413" left="258" width="8" height="7" font="font8" id="p1_t144" reading_order_no="71" segment_no="4" tag_type="table">21</text>
<text top="424" left="59" width="33" height="7" font="font8" id="p1_t145" reading_order_no="72" segment_no="4" tag_type="table">Mean Age</text>
<text top="424" left="181" width="28" height="7" font="font8" id="p1_t146" reading_order_no="73" segment_no="4" tag_type="table">46 years</text>
<text top="424" left="248" width="28" height="7" font="font8" id="p1_t147" reading_order_no="74" segment_no="4" tag_type="table">42 years</text>
<text top="434" left="59" width="56" height="7" font="font8" id="p1_t148" reading_order_no="75" segment_no="4" tag_type="table">Mean Age Onset</text>
<text top="434" left="181" width="28" height="7" font="font8" id="p1_t149" reading_order_no="76" segment_no="4" tag_type="table">36 years</text>
<text top="444" left="59" width="37" height="7" font="font8" id="p1_t150" reading_order_no="77" segment_no="4" tag_type="table">Onset type</text>
<text top="454" left="69" width="24" height="7" font="font8" id="p1_t151" reading_order_no="78" segment_no="4" tag_type="table">Sudden</text>
<text top="454" left="193" width="4" height="7" font="font8" id="p1_t152" reading_order_no="79" segment_no="4" tag_type="table">5</text>
<text top="465" left="69" width="27" height="7" font="font8" id="p1_t153" reading_order_no="80" segment_no="4" tag_type="table">Gradual</text>
<text top="465" left="191" width="8" height="7" font="font8" id="p1_t154" reading_order_no="81" segment_no="4" tag_type="table">32</text>
<text top="475" left="59" width="73" height="7" font="font8" id="p1_t155" reading_order_no="82" segment_no="4" tag_type="table">Mean Illness Duration</text>
<text top="475" left="175" width="40" height="7" font="font8" id="p1_t156" reading_order_no="83" segment_no="4" tag_type="table">128 months</text>
<text top="485" left="59" width="75" height="7" font="font8" id="p1_t157" reading_order_no="84" segment_no="4" tag_type="table">Number of Subjects Ill</text>
<text top="495" left="69" width="31" height="7" font="font8" id="p1_t158" reading_order_no="85" segment_no="4" tag_type="table">&lt; 5 years</text>
<text top="495" left="191" width="8" height="7" font="font8" id="p1_t159" reading_order_no="86" segment_no="4" tag_type="table">14</text>
<text top="506" left="69" width="29" height="7" font="font8" id="p1_t160" reading_order_no="87" segment_no="4" tag_type="table">&gt;5 years</text>
<text top="506" left="191" width="8" height="7" font="font8" id="p1_t161" reading_order_no="88" segment_no="4" tag_type="table">23</text>
</page>
</pdf2xml>
